Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,018 total articles

SVF Sponsor III Divests Major Stake in Symbotic; Mixed Quarterly Results and Insider Sales Mark Activity

SVF Sponsor III Divests Major Stake in Symbotic; Mixed Quarterly Results and Insider Sales Mark Activity

SVF Sponsor III (DE) LLC, an affiliate linked to SoftBank Group Corp., executed a substantial sale of Symbotic Inc. shares on May 27, 2026. This transaction signals a reduction in institutional holding by the entity. Separately, Symbotic released its second-quarter financial results for fiscal year 2026, reporting revenue that surpassed expectation…

Director OrbiMed Advisors Sells Sionna Therapeutics Stock Under Pre-Arranged Plan Amid Analyst Upgrades

Director OrbiMed Advisors Sells Sionna Therapeutics Stock Under Pre-Arranged Plan Amid Analyst Upgrades

OrbiMed Advisors LLC, which is listed as a director for Sionna Therapeutics, Inc., reported the sale of common stock on May 27, 2026. The transaction involved the disposal of 101 shares at $44.49 per share, totaling $4,493. This activity occurred while the company's stock traded near $42.81 and maintains a market capitalization of $1.93 billion.Des…

Director's Stock Sales at Turtle Beach Provide Insider View

Director's Stock Sales at Turtle Beach Provide Insider View

Turtle Beach director Katherine Lee Scherping recently completed multiple sales totaling $116,152 in the company's common stock. These transactions occurred between May 27 and May 29, 2026. Separately, the company announced several key changes to its board of directors, including new appointments and one resignation.

Executive Sales and Analyst Views on CrowdStrike's Stock Activity

Executive Sales and Analyst Views on CrowdStrike's Stock Activity

CrowdStrike CEO George Kurtz reported selling a total of approximately $1.48 million worth of company stock over May 27-29, 2026, utilizing a previously established trading plan. This activity occurred while the stock traded near its 52-week high. Despite the executive sales, recent analyst reports have featured mixed recommendations, with some fir…

Executive Stock Sales and Snowflake's Strong Q1 Performance Signal Divergent Views on Cloud Data Platform

Executive Stock Sales and Snowflake's Strong Q1 Performance Signal Divergent Views on Cloud Data Platform

Executive Vice President Christian Kleinerman disposed of company stock after utilizing a 10b5-1 trading plan. This activity occurred against the backdrop of Snowflake Inc.'s robust first-quarter fiscal 2027 results. The strong performance, marked by significant revenue and operating income growth, led several financial firms to adjust their price …

Insider Activity and Operational Updates at Nexgel Inc.: Analysis of Executive Stock Sales Amid Company Milestones

Insider Activity and Operational Updates at Nexgel Inc.: Analysis of Executive Stock Sales Amid Company Milestones

Nexgel CEO Adam R. Levy executed three separate transactions in late May, selling a total of 13,000 shares of the company's common stock for approximately $7,834. The report details these insider sales alongside recent corporate developments, including Q1 2026 financial results and promising clinical study outcomes for the firm's hydrogel patch.